1
|
Tioyama EC, Bayona-Serrano JD, Portes-Junior JA, Nachtigall PG, de Souza VC, Beraldo-Neto E, Grazziotin FG, Junqueira-de-Azevedo ILM, Moura-da-Silva AM, Freitas-de-Sousa LA. The Venom Composition of the Snake Tribe Philodryadini: 'Omic' Techniques Reveal Intergeneric Variability among South American Racers. Toxins (Basel) 2023; 15:415. [PMID: 37505684 PMCID: PMC10467154 DOI: 10.3390/toxins15070415] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/15/2023] [Revised: 05/31/2023] [Accepted: 06/03/2023] [Indexed: 07/29/2023] Open
Abstract
Snakes of the Philodryadini tribe are included in the Dipsadidae family, which is a diverse group of rear-fanged snakes widespread in different ecological conditions, including habitats and diet. However, little is known about the composition and effects of their venoms despite their relevance for understanding the evolution of these snakes or even their impact on the occasional cases of human envenoming. In this study, we integrated venom gland transcriptomics, venom proteomics and functional assays to characterize the venoms from eight species of the Philodryadini tribe, which includes the genus Philodryas, Chlorosoma and Xenoxybelis. The most abundant components identified in the venoms were snake venom metalloproteinases (SVMPs), cysteine-rich secretory proteins (CRISPs), C-type lectins (CTLs), snake endogenous matrix metalloproteinases type 9 (seMMP-9) and snake venom serinoproteinases (SVSPs). These protein families showed a variable expression profile in each genus. SVMPs were the most abundant components in Philodryas, while seMMP-9 and CRISPs were the most expressed in Chlorosoma and Xenoxybelis, respectively. Lineage-specific differences in venom composition were also observed among Philodryas species, whereas P. olfersii presented the highest amount of SVSPs and P. agassizii was the only species to express significant amounts of 3FTx. The variability observed in venom composition was confirmed by the venom functional assays. Philodryas species presented the highest SVMP activity, whereas Chlorosoma species showed higher levels of gelatin activity, which may correlate to the seMMP-9 enzymes. The variability observed in the composition of these venoms may be related to the tribe phylogeny and influenced by their diets. In the presented study, we expanded the set of venomics studies of the Philodryadini tribe, which paves new roads for further studies on the evolution and ecology of Dipsadidae snakes.
Collapse
Affiliation(s)
- Emilly Campos Tioyama
- Programa de Pós-Graduação em Ciências-Toxinologia, Escola Superior do Instituto Butantan, São Paulo 05508-210, Brazil; (E.C.T.); (J.D.B.-S.)
- Laboratório de Imunopatologia, Instituto Butantan, São Paulo 05503-900, Brazil; (J.A.P.-J.); (A.M.M.-d.-S.)
| | - Juan David Bayona-Serrano
- Programa de Pós-Graduação em Ciências-Toxinologia, Escola Superior do Instituto Butantan, São Paulo 05508-210, Brazil; (E.C.T.); (J.D.B.-S.)
- Laboratório de Toxinologia Aplicada, Instituto Butantan, São Paulo 05503-900, Brazil; (P.G.N.); (V.C.d.S.); (I.L.M.J.-d.-A.)
| | - José A. Portes-Junior
- Laboratório de Imunopatologia, Instituto Butantan, São Paulo 05503-900, Brazil; (J.A.P.-J.); (A.M.M.-d.-S.)
| | - Pedro Gabriel Nachtigall
- Laboratório de Toxinologia Aplicada, Instituto Butantan, São Paulo 05503-900, Brazil; (P.G.N.); (V.C.d.S.); (I.L.M.J.-d.-A.)
| | - Vinicius Carius de Souza
- Laboratório de Toxinologia Aplicada, Instituto Butantan, São Paulo 05503-900, Brazil; (P.G.N.); (V.C.d.S.); (I.L.M.J.-d.-A.)
| | - Emidio Beraldo-Neto
- Laboratório de Bioquímica e Biofísica, Instituto Butantan, São Paulo 05503-900, Brazil;
| | | | | | - Ana Maria Moura-da-Silva
- Laboratório de Imunopatologia, Instituto Butantan, São Paulo 05503-900, Brazil; (J.A.P.-J.); (A.M.M.-d.-S.)
| | | |
Collapse
|
2
|
Gritti MA, González KY, Tavares FL, Teibler GP, Peichoto ME. Exploring the antibacterial potential of venoms from Argentinian animals. Arch Microbiol 2023; 205:121. [PMID: 36934358 DOI: 10.1007/s00203-023-03465-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/07/2022] [Revised: 02/27/2023] [Accepted: 03/03/2023] [Indexed: 03/20/2023]
Abstract
The resistance to antimicrobials developed by several bacterial species has become one of the main health problems in recent decades. It has been widely reported that natural products are important sources of antimicrobial compounds. Considering that animal venoms are under-explored in this line of research, in this study, we screened the antibacterial activity of venoms of eight snake and five lepidopteran species from northeastern Argentina. Twofold serial dilutions of venoms were tested by the agar well-diffusion method and the minimum inhibitory concentration (MIC) determination against seven bacterial strains. We studied the comparative protein profile of the venoms showing antibacterial activity. Only the viperid and elapid venoms showed remarkable dose-dependent antibacterial activity towards most of the strains tested. Bothrops diporus venom showed the lowest MIC values against all the strains, and S. aureus ATCC 25923 was the most sensitive strain for all the active venoms. Micrurus baliocoryphus venom was unable to inhibit the growth of Enterococcus faecalis. Neither colubrid snake nor lepidopteran venoms exhibited activity on any bacterial strain tested. The snake venoms exhibiting antibacterial activity showed distinctive protein profiles by SDS-PAGE, highlighting that we could reveal for the first time the main protein families which may be thought to contribute to the antibacterial activity of M. baliocoryphus venom. This study paves the way to search for new antibacterial agents from Argentinian snake venoms, which may be a further opportunity to give an added value to the local biodiversity.
Collapse
Affiliation(s)
- Micaela A Gritti
- Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina
- Instituto Nacional de Medicina Tropical (INMeT)-ANLIS "Dr. Carlos G Malbrán", Almafuerte y Ambar s/n, 3370, Puerto Iguazú, Argentina
| | - Karen Y González
- Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina
- Facultad de Ciencias Veterinarias (FCV), Universidad Nacional del Nordeste (UNNE), Sargento Cabral 2139, 3400, Corrientes, Argentina
| | - Flavio L Tavares
- Universidade Federal da Integração Latino-Americana (UNILA), Av. Tarquínio Joslin dos Santos, nº. 1.000, Jd. Universitário, Foz do Iguaçu, PR, CEP 85870-901, Brazil
| | - Gladys P Teibler
- Facultad de Ciencias Veterinarias (FCV), Universidad Nacional del Nordeste (UNNE), Sargento Cabral 2139, 3400, Corrientes, Argentina
| | - María E Peichoto
- Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina.
- Instituto Nacional de Medicina Tropical (INMeT)-ANLIS "Dr. Carlos G Malbrán", Almafuerte y Ambar s/n, 3370, Puerto Iguazú, Argentina.
- Universidade Federal da Integração Latino-Americana (UNILA), Av. Tarquínio Joslin dos Santos, nº. 1.000, Jd. Universitário, Foz do Iguaçu, PR, CEP 85870-901, Brazil.
| |
Collapse
|
3
|
Urra FA, Vivas-Ruiz DE, Sanchez EF, Araya-Maturana R. An Emergent Role for Mitochondrial Bioenergetics in the Action of Snake Venom Toxins on Cancer Cells. Front Oncol 2022; 12:938749. [PMID: 35924151 PMCID: PMC9343075 DOI: 10.3389/fonc.2022.938749] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/08/2022] [Accepted: 06/14/2022] [Indexed: 01/09/2023] Open
Abstract
Beyond the role of mitochondria in apoptosis initiation/execution, some mitochondrial adaptations support the metastasis and chemoresistance of cancer cells. This highlights mitochondria as a promising target for new anticancer strategies. Emergent evidence suggests that some snake venom toxins, both proteins with enzymatic and non-enzymatic activities, act on the mitochondrial metabolism of cancer cells, exhibiting unique and novel mechanisms that are not yet fully understood. Currently, six toxin classes (L-amino acid oxidases, thrombin-like enzymes, secreted phospholipases A2, three-finger toxins, cysteine-rich secreted proteins, and snake C-type lectin) that alter the mitochondrial bioenergetics have been described. These toxins act through Complex IV activity inhibition, OXPHOS uncoupling, ROS-mediated permeabilization of inner mitochondrial membrane (IMM), IMM reorganization by cardiolipin interaction, and mitochondrial fragmentation with selective migrastatic and cytotoxic effects on cancer cells. Notably, selective internalization and direct action of snake venom toxins on tumor mitochondria can be mediated by cell surface proteins overexpressed in cancer cells (e.g. nucleolin and heparan sulfate proteoglycans) or facilitated by the elevated Δψm of cancer cells compared to that non-tumor cells. In this latter case, selective mitochondrial accumulation, in a Δψm-dependent manner, of compounds linked to cationic snake peptides may be explored as a new anti-cancer drug delivery system. This review analyzes the effect of snake venom toxins on mitochondrial bioenergetics of cancer cells, whose mechanisms of action may offer the opportunity to develop new anticancer drugs based on toxin scaffolds.
Collapse
Affiliation(s)
- Félix A. Urra
- Laboratorio de Plasticidad Metabólica y Bioenergética, Programa de Farmacología Clínica y Molecular, Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, Santiago, Chile
- Network for Snake Venom Research and Drug Discovery, Santiago, Chile
- Interdisciplinary Group on Mitochondrial Targeting and Bioenergetics (MIBI), Talca, Chile
- *Correspondence: Félix A. Urra,
| | - Dan E. Vivas-Ruiz
- Network for Snake Venom Research and Drug Discovery, Santiago, Chile
- Laboratorio de Biología Molecular, Facultad de Ciencias Biológicas, Universidad Nacional Mayor de San Marcos, Ciudad Universitaria, Lima, Peru
| | - Eladio Flores Sanchez
- Network for Snake Venom Research and Drug Discovery, Santiago, Chile
- Laboratory of Biochemistry of Proteins from Animal Venoms, Research and Development Center, Ezequiel Dias Foundation, Belo Horizonte, Brazil
| | - Ramiro Araya-Maturana
- Network for Snake Venom Research and Drug Discovery, Santiago, Chile
- Interdisciplinary Group on Mitochondrial Targeting and Bioenergetics (MIBI), Talca, Chile
- Laboratorio de Productos Bioactivos, Instituto de Química de Recursos Naturales, Universidad de Talca, Talca, Chile
| |
Collapse
|
4
|
Oliveira AL, Viegas MF, da Silva SL, Soares AM, Ramos MJ, Fernandes PA. The chemistry of snake venom and its medicinal potential. Nat Rev Chem 2022; 6:451-469. [PMID: 37117308 PMCID: PMC9185726 DOI: 10.1038/s41570-022-00393-7] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/26/2022] [Indexed: 12/15/2022]
Abstract
The fascination and fear of snakes dates back to time immemorial, with the first scientific treatise on snakebite envenoming, the Brooklyn Medical Papyrus, dating from ancient Egypt. Owing to their lethality, snakes have often been associated with images of perfidy, treachery and death. However, snakes did not always have such negative connotations. The curative capacity of venom has been known since antiquity, also making the snake a symbol of pharmacy and medicine. Today, there is renewed interest in pursuing snake-venom-based therapies. This Review focuses on the chemistry of snake venom and the potential for venom to be exploited for medicinal purposes in the development of drugs. The mixture of toxins that constitute snake venom is examined, focusing on the molecular structure, chemical reactivity and target recognition of the most bioactive toxins, from which bioactive drugs might be developed. The design and working mechanisms of snake-venom-derived drugs are illustrated, and the strategies by which toxins are transformed into therapeutics are analysed. Finally, the challenges in realizing the immense curative potential of snake venom are discussed, and chemical strategies by which a plethora of new drugs could be derived from snake venom are proposed.
Collapse
Affiliation(s)
- Ana L Oliveira
- Department of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, Porto, Portugal.,LAQV/Requimte, University of Porto, Porto, Portugal
| | - Matilde F Viegas
- Department of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, Porto, Portugal.,LAQV/Requimte, University of Porto, Porto, Portugal
| | - Saulo L da Silva
- Department of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, Porto, Portugal.,LAQV/Requimte, University of Porto, Porto, Portugal
| | - Andreimar M Soares
- Biotechnology Laboratory for Proteins and Bioactive Compounds from the Western Amazon, Oswaldo Cruz Foundation, National Institute of Epidemiology in the Western Amazon (INCT-EpiAmO), Porto Velho, Brazil.,Sao Lucas Universitary Center (UniSL), Porto Velho, Brazil
| | - Maria J Ramos
- Department of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, Porto, Portugal.,LAQV/Requimte, University of Porto, Porto, Portugal
| | - Pedro A Fernandes
- Department of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, Porto, Portugal.,LAQV/Requimte, University of Porto, Porto, Portugal
| |
Collapse
|